Ivermectin for the Treatment of COVID-19 Disease: Too Good to Pass Up or Too Good to Be True?

Mark J Siedner^{1

2

3}

Affiliations

¹ Harvard Medical School, Boston, Massachusetts, USA.
² Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Africa Health Research Institute, KwaZulu-Natal, South Africa.

Editorial

Mark J Siedner. Open Forum Infect Dis. 2021.

. 2021 Jun 14;8(11):ofab318.

doi: 10.1093/ofid/ofab318. eCollection 2021 Nov.

Mark J Siedner^{1

2

3}

¹ Harvard Medical School, Boston, Massachusetts, USA.
² Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Africa Health Research Institute, KwaZulu-Natal, South Africa.

No abstract available

Comment in

RETRACTED: Expression of Concern: "Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection".
Hill A, Garratt A, Levi J, Falconer J, Ellis L, McCann K, Pilkington V, Qavi A, Wang J, Wentzel H. Hill A, et al. Open Forum Infect Dis. 2021 Aug 9;8(8):ofab394. doi: 10.1093/ofid/ofab394. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34410284 Free PMC article. No abstract available.

1. The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384:693–704. - PMC - PubMed
1. Beigel JH, Tomashek KM, Dodd LE, et al. . Remdesivir for the treatment of Covid-19 – final report. N Engl J Med 2020; 383:1813–26. - PMC - PubMed
1. Horby P, Mafham M, Linsell L, et al. ; RECOVERY Collaborative Group . Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 383:2030–40. - PMC - PubMed
1. WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19 — interim WHO solidarity trial results. N Engl J Med. 2021; 384:497–511. - PMC - PubMed
1. Kalil AC. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA 2020; 323:1897–8. - PubMed